The deep learning-based software, called the AI-CT Stroke Screening System, is designed to help radiologists quickly determine the type, location, and severity of a stroke using a patient's brain CT scans, according to the company.
In patients with hemorrhagic stroke, the algorithm can accurately spot the location of the bleed and measure the amount of blood volume, the company said. As MRI scans are usually less available than CT studies, the AI-CT Stroke Screening System can also be used to help physicians detect signs of ischemic stroke on brain CT, providing more stroke information for clinical intervention, Infervision said.
Radiologists at Beijing Tian Tan Hospital are currently testing the platform, which is the second developed by the firm. Infervision's initial platform -- AI-CT Lung Screening System and AI-DR Lung Screening System -- is aimed at assisting radiologists in detecting lung cancer and other cardiothoracic disease on chest CT and x-ray exams.